Zdrowie i gospodarka · 08/07/1998
FDA Withdraws Approval for Combination Drugs Containing Theophylline, Ephedrine Sulfate, and Hydroxyzine Hydrochloride
The FDA is withdrawing approval for Marax Tablets and Marax Syrup, as well as other related products, due to a lack of substantial evidence showing their effectiveness in treating bronchial asthma.